Key result
Prolonged elevated heart rate linked to ~116% higher mortality risk in acute COPD exacerbations.
Why the study?
The relationship between prolonged elevated heart rate and clinical outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease remains unclear.
Does prolonged elevated heart rate increase 28-day mortality in ICU patients with acute exacerbations of chronic obstructive pulmonary disease?
Cohort (n=931)
No
Does prolonged elevated heart rate increase 28-day mortality in ICU patients with acute exacerbations of chronic obstructive pulmonary disease?
Effect estimate: HR 2.16 (95% CI 1.62-2.87)
Absolute Event Rate: 30.3% vs 15.8%
p-value: p=<0.001
Prolonged elevated heart rate (>100 bpm for ≥11 hours within a 12-hour period) is an independent predictor of 28-day mortality in ICU patients with acute exacerbations of COPD.
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) represent a significant global health burden, and severe exacerbations are associated with worse prognoses. We defined prolonged elevated heart rate (PeHR) as a heart rate exceeding 100 beats per minute for at least 11 h within any continuous 12-hour period. However, the relationship between PeHR and outcomes in patients with AECOPD remains unclear. We identified AECOPD patients in the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database and divided them into two groups according to the presence or absence of PeHR. The primary outcome was 28-day mortality. We evaluated the association between PeHR and 28-day mortality using multivariable Cox proportional-hazards models and propensity-score matching. A total of 931 patients with AECOPD were included, 49.6% of whom were male. PeHR occurred in 30.0% of patients. The overall mean age was 72.1 years, and patients with PeHR were younger than those without (71.1 vs. 72.5 years; P < 0.001). Twenty-eight-day mortality was significantly higher in the PeHR group compared with the non-PeHR group (30.3% vs. 15.8%; P < 0.001). In multivariable Cox regression, PeHR was an independent risk factor for 28-day mortality (hazard ratio, 2.16; 95% CI, 1.62-2.87; P < 0.001). After propensity-score matching, the increased mortality in the PeHR group persisted. Prespecified subgroup analyses showed generally consistent effect sizes across all subgroups. PeHR is independently associated with increased 28-day mortality in patients with AECOPD.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) conducted a cohort in Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) (n=931). Prolonged elevated heart rate (PeHR) vs. Absence of PeHR was evaluated on 28-day mortality (HR 2.16, 95% CI 1.62-2.87, p=<0.001). Prolonged elevated heart rate was independently associated with a significantly increased risk of 28-day mortality (HR 2.16) in patients with acute exacerbations of chronic obstructive pulmonary disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: